Japanese Language pdf - 460 kbDxS is a personalised medicine company providing cancer mutation products, technologies and genetic analysis services to enable the delivery of safe and effective medicines.

News Flash – "Genzyme Announces Sublicense Agreement with DxS" - click here for information

*Corporate - - Company Profile, - The DxS Team, - Recruitment, - News, - Events Calendar.
DxS - Diagnostic InnovationsCancer Mutation Products - - TheraScreen: K-RAS, - TheraScreen: EGFR29, - EGFR Mutation Test Kit, - Extended EGFR 29 Mutation Kit, - T790M EGFR Mutation Test Kit, - K-RAS Mutation Kit, - B-RAF Mutation Test Kit, - ABL-T315I Mutation Test Kit.
DxS - Diagnostic InnovationsMolecular Diagnostic Technologies - - The Scorpions Reaction, - Scorpions Performance Data, - Product Development, - Scorpions Licensing, - ARMS Technology, - Bibliography.
DxS - Diagnostic InnovationsGenetic Analysis Services - - Clinical Genotyping, - Tumour Mutation Analysis, - DNA Extraction, - Project Management, - Quality Assurance.
DxS - Diagnostic InnovationsContact Us - - Facilities and Location, - Directions, - Links.
DxS - Diagnostic Innovations
Diagnostic Innovations